Ventyx Biosciences shares rose 29% after The Wall Street Journal reported that the company is in advanced talks to be ...

Here's how we employ swing trading strategies of selling into strength, selling into weakness and cutting a loss quickly.

Aktis Oncology (AKTS) stock surged after an upsized Nasdaq IPO aimed at raising ~$318M with the help of its partner Eli Lilly ...

Highly rated Eli Lilly stock is this week's Big Cap 20 pick to watch as it attempts to take out a flat-base buy point.

Eli Lilly (NYSE: LLY) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in ...

Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable ...

Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...

Eli Lilly stock reached an all-time high of 1113.03 USD, marking a significant milestone for the pharmaceutical giant. This achievement reflects a robust 41.51% increase over the past year, ...

Eli Lilly will buy autoimmune drug developer Ventyx Biosciences for $1.2 billion in cash, the companies said on Wednesday, ...

Eli Lilly and Company (NYSE:LLY) operates as a global pharmaceutical firm focused on discovering, developing, manufacturing, ...

Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.

Today, Zacks Investment Ideas feature highlights Pagaya Technologies Ltd. PGY, Eli Lilly LLY and Weatherford Internation ...